Xpert Xpress Strep A
FDA 510(k) K172126 · Cepheid
510(k) numberK172126
Submission
- Device name
- Xpert Xpress Strep A
- Applicant
- Cepheid
Sunnyvale, CA, US - Received
- July 14, 2017
- Decision date
- September 25, 2017
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- PGX – Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.2680
- Specialty
- Microbiology
An in vitro diagnostic test for the detection of Group A, C and G beta hemolytic Streptococcus in throat swab specimens from symptomatic patients.
Other 510(k)s with product code PGX
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K260047 | cobas Strep A Nucleic acid test for use on the cobas Liat System (07341911190); cobas…PGX · Traditional | Roche Molecular Systems, Inc. | 08/28/2026SE |
| K260333 | LIAISON NES Group A Strep; LIAISON NES Group A Strep Control Swab KitPGX · Dual Track | Diasorin Molecular, LLC | 06/15/2026SE |
| K201269 | Accula Strep A TestPGX · Dual Track | Mesa Biotech, Inc. | 11/09/2020SE |
| K183366 | GenePOC Strep APGX · Traditional | Genepoc, Inc. | 03/06/2019SE |
| K173653 | Alere i Strep A 2, Alere i instrument, Alere i Strep A 2 Control Swab KitPGX · Dual Track | Alere Scarborough, Inc. | 05/02/2018SE |
| K173398 | Xpert Xpress Strep APGX · Dual Track | Cepheid | 04/26/2018SE |
| K172402 | ARIES Group A Strep Assay, ARIES Group A Strep Assay Protocol File KitPGX · Traditional | Luminex Corporation | 10/30/2017SE |
| K162274 | Solana Strep Complete AssayPGX · Traditional | Quidel Corporation | 10/25/2016SE |
| K150868 | Solana GAS Assay, Solana instrumentPGX · Traditional | Quidel Corporation | 06/23/2015SE |
| K141757 | Alere I Strep aPGX · Traditional | Alere Scarborough, Inc. | 03/31/2015SE |
More from Alere Scarborough, Inc.
| 510(k) | Device | Decision |
|---|---|---|
| K261362 | Xpert Hemorrhagic FeverQVR · Dual Track | 08/07/2026SE |
| K261867 | Xpert Carba-RPOC · Special | 07/02/2026SE |
| K253653 | Xpert Hemorrhagic Fever · Traditional | 02/20/2026SE |
| K251721 | Xpert GI PanelPCH · Traditional | 01/16/2026SE |
| K250996 | Xpert Xpress CoV-2/Flu/RSV plusQOF · Special | 05/01/2025SE |
| K250995 | Xpert Xpress CoV-2/Flu/RSV plusQOF · Special | 05/01/2025SE |
| K243730 | Xpert C. difficile/EpiOZN · Traditional | 02/28/2025SE |
| K250218 | Xpert® FII & FVNPR · Special | 02/21/2025SE |
| K242109 | Xpert® Xpress CoV-2 plus (XPRS-COV2-10)QQX · Dual Track | 01/15/2025SE |
| K242071 | Xpert Xpress CoV-2/Flu/RSV plusQOF · Dual Track | 01/10/2025SE |
Questions and answers
When was Xpert Xpress Strep A cleared by the FDA?
Xpert Xpress Strep A (K172126) received a 510(k) decision of Substantially Equivalent on September 25, 2017, 73 days after the submission was received.
What is the product code of K172126?
The FDA product code is PGX – Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System, a Class II (moderate risk) device regulated under 21 CFR 866.2680.